Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

Conditions:   Type 1 Diabetes;   Type 1 Diabetes Mellitus;   Hyperglycemia, Postprandial Interventions:   Drug: Fiasp;   Drug: Pramlintide Acetate;   Drug: Placebo;   Device: Artificial Pancreas Sponsors:   McGill University;   Juvenile Diabetes Research Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials